While peptide therapy may be appropriate for some individuals, it is not necessarily suitable for everyone
While we still lack safety trial data for DSIP, early studies suggest that even at low doses DSIP can normalize sleep and exert strong neuroprotective effects
In a cellular model of dopamine neurotoxicity induced by fisetinone, silencing of PGC-1 expression was found to significantly increase the protein expression levels of PINK1, parkin, and their phosphorylated proteins (Peng et al., 2019)
Moreover, although Ang-1 and Ang-2 are not known drugs for protecting the glycocalyx, intervening in Ang-1 and Ang-2 may serve as targets for inhibiting glycocalyx degradation
Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals
Eligible participants were aged 1855 years with a BMI range of 27.039.9 without diabetes or CVD